Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Please consult the latest package insert
The expanded approval was based on data from the Phase III EoE KIDS trial, where 66% of children who received the higher dose Dupixent at tiered dosing regimens experienced histological disease remission after 16 weeks of treatment, compared to just 3% in the placebo group, per the press release
Below is the calculating formula: Statistical analysis Statistical examination SPSS 19.0 was used for data analysis
The pathogenicity of the SsCm1 mutants on different hosts was significantly reduced compared with the UF-1 and the complemented strain, whereas no significant variations among these strains were detected in colony morphology, hyphal growth rate, compound appressorium formation, sclerotium development, OA production, and content of cell wall hydrolase (Fig
US$ 26.35
)
US$ 26.17
US$ 29.24
US$ 21.39
US$ 20.41
US$ 22.22
US$ 20.71
